KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) Research & Development (2016 - 2025)

Incyte (INCY) has disclosed Research & Development for 16 consecutive years, with $611.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development rose 31.19% year-over-year to $611.4 million, compared with a TTM value of $2.1 billion through Dec 2025, down 21.36%, and an annual FY2025 reading of $2.1 billion, down 21.36% over the prior year.
  • Research & Development was $611.4 million for Q4 2025 at Incyte, up from $506.6 million in the prior quarter.
  • Across five years, Research & Development topped out at $1.1 billion in Q2 2024 and bottomed at $306.9 million in Q1 2021.
  • Average Research & Development over 5 years is $466.4 million, with a median of $433.3 million recorded in 2024.
  • The sharpest move saw Research & Development crashed 71.72% in 2021, then surged 184.06% in 2024.
  • Year by year, Research & Development stood at $472.8 million in 2021, then increased by 6.03% to $501.4 million in 2022, then fell by 11.34% to $444.5 million in 2023, then rose by 4.85% to $466.0 million in 2024, then skyrocketed by 31.19% to $611.4 million in 2025.
  • Business Quant data shows Research & Development for INCY at $611.4 million in Q4 2025, $506.6 million in Q3 2025, and $494.9 million in Q2 2025.